Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Total 13F shares
-
28,567,397
-
Share change
-
+2,129,250
-
Total reported value
-
$812,623,475
-
Put/Call ratio
-
0.04%
-
Price per share
-
$28.45
-
Number of holders
-
134
-
Value change
-
+$71,804,541
-
Number of buys
-
75
-
Number of sells
-
56
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q1 2018
As of 31 Mar 2018,
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) was held by
134 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,567,397 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MILLENNIUM MANAGEMENT LLC, and Invesco Ltd..
This page lists
135
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.